Peer Review History

Original SubmissionFebruary 2, 2024
Decision Letter - Geraldine Butler, Editor, Joseph Heitman, Editor

Dear David,

Thank you very much for submitting your exciting Research Article entitled 'Mendelian segregation and high recombination rates facilitate genetic analyses in Cryptosporidium parvum.' to PLOS Genetics.

The manuscript was fully evaluated at the editorial level and by three independent peer reviewers. The reviewers appreciated the attention to an important topic but identified some concerns that we ask you address in a revised manuscript. I apologize for the delay in returning this to you.  Two of the reviewers were a bit delayed beyond the deadline, and it took a couple of additional weeks for the third review to arrive. 

Given the topic of the paper, I have also read it over myself.  One area that I think needs revision has to do with the expectation/prediction for segregation of two unlinked markers following a standard meiosis.  From yeast genetics we know that segregation of two unlinked markers (and which are not centromere linked), will yield parental ditypes (PD), nonparental ditypes (NPD), and tetratypes (TT), if all four meiotic products from a given tetrad are analyzed.  For two unlinked markers, the ratio is PD:NPD:TT of 1:1:4.  Thus, on average you expect about 66% of the progeny to be tetratype.  Thus, it isn't clear why these are suggested to be rare in Figure 2.  In the actual data, the vast majority of your progeny are TT, in accord with this expectation. They are in fact over-represented, so you want to think about why that is the case.  This was also noted by two of the reviewers.

I don't think you need any additional data from what I can see.  Just revisions to the presentation, models, interpretation.

We therefore ask you to modify the manuscript according to the review recommendations. Your revisions should address the specific points made by each reviewer.

In addition we ask that you:

1) Provide a detailed list of your responses to the review comments and a description of the changes you have made in the manuscript.

2) Upload a Striking Image with a corresponding caption to accompany your manuscript if one is available (either a new image or an existing one from within your manuscript). If this image is judged to be suitable, it may be featured on our website. Images should ideally be high resolution, eye-catching, single panel square images. For examples, please browse our archive. If your image is from someone other than yourself, please ensure that the artist has read and agreed to the terms and conditions of the Creative Commons Attribution License. Note: we cannot publish copyrighted images.

We hope to receive your revised manuscript within the next 30 days. If you anticipate any delay in its return, we would ask you to let us know the expected resubmission date by email to plosgenetics@plos.org.

If present, accompanying reviewer attachments should be included with this email; please notify the journal office if any appear to be missing. They will also be available for download from the link below. You can use this link to log into the system when you are ready to submit a revised version, having first consulted our Submission Checklist.

While revising your submission, please upload your figure files to the Preflight Analysis and Conversion Engine (PACE) digital diagnostic tool. PACE helps ensure that figures meet PLOS requirements. To use PACE, you must first register as a user. Then, login and navigate to the UPLOAD tab, where you will find detailed instructions on how to use the tool. If you encounter any issues or have any questions when using PACE, please email us at figures@plos.org.

Please be aware that our data availability policy requires that all numerical data underlying graphs or summary statistics are included with the submission, and you will need to provide this upon resubmission if not already present. In addition, we do not permit the inclusion of phrases such as "data not shown" or "unpublished results" in manuscripts. All points should be backed up by data provided with the submission.

To enhance the reproducibility of your results, we recommend that you deposit your laboratory protocols in protocols.io, where a protocol can be assigned its own identifier (DOI) such that it can be cited independently in the future. Additionally, PLOS ONE offers an option to publish peer-reviewed clinical study protocols. Read more information on sharing protocols at https://plos.org/protocols?utm_medium=editorial-email&utm_source=authorletters&utm_campaign=protocols

Please review your reference list to ensure that it is complete and correct. If you have cited papers that have been retracted, please include the rationale for doing so in the manuscript text, or remove these references and replace them with relevant current references. Any changes to the reference list should be mentioned in the rebuttal letter that accompanies your revised manuscript. If you need to cite a retracted article, indicate the article’s retracted status in the References list and also include a citation and full reference for the retraction notice.

PLOS has incorporated Similarity Check, powered by iThenticate, into its journal-wide submission system in order to screen submitted content for originality before publication. Each PLOS journal undertakes screening on a proportion of submitted articles. You will be contacted if needed following the screening process.

To resubmit, you will need to go to the link below and 'Revise Submission' in the 'Submissions Needing Revision' folder.

Please let us know if you have any questions while making these revisions.  Thank you for submitting this exciting study to PLOS Genetics!   And again, my apologies for the delay in getting this back to you with reviews.

Yours sincerely,

Joe

Joseph Heitman, MD, PhD

Academic Editor

PLOS Genetics

Geraldine Butler

Section Editor

PLOS Genetics

Reviewer's Responses to Questions

Comments to the Authors:

Please note here if the review is uploaded as an attachment.

Reviewer #1: This is a highly innovative study that will be an excellent addition to the literature on this parasite.

The manuscript is well written, and the results are statistically relevant, and the figs and tables of a high standard.

One minor point; Could the authors clarify the analysis for quantitating oocyst shedding in mouse experiments which is based on a single sporozoite giving rise to an oocyst (line 400 - the average oocyst count is divided by four, since the oocyst contains four sporozoites). The calculation does not seem to take into account that not all merozoites (the progeny of sporozoites) result in male and female gametes. This may explain why they do not see perfect outcrossing from in vivo experiments.

Reviewer #2: The authors investigated meiotic recombination in the apicomplexan parasite Cryptosporidium parvum. My background is in yeast genetics and I was not familiar with the life cycle of C. parvum before reading this manuscript, but the Introduction provided a good crash course in its biology. It is fascinating that the oocyst, which is equivalent to the ascus in yeast (it contains 4 haploid progeny from a meiosis), is the infectious agent in this organism. The standard laboratory culture protocol for growth of C. parvum cultures (incubation in HCT-8 adenocarcinoma cells) does not induce production of oocysts so it has previously been impossible to study the sexual cycle. However, in 2019 (ref. 10) the authors’ laboratory developed a growth method (ALI cultures) that produces oocytes, and this innovation has enabled them to study the meiotic inheritance of genetic markers in the current manuscript.

The manuscript is first detailed study of genetic crosses in Cryptosporidium. The results indicate that C. parvum outcrosses readily, and that it has a high recombination rate. The work is welcome because it is a significant technical achievement, laying the foundation for future genetic crossing and analysis (e.g. QTL analysis) in this important pathogenic species. Overall, the manuscript was written in a clear style that was accessible to this reader.

Major comment

Perhaps I have misunderstood something, but in the cross in Figure 2, I don’t understand why the authors expect the frequency of Tetratype (TT) oocysts to be low. This cross involves markers that are on two different chromosomes (uprt-mCherry on chr. 1, and tk-GFP on chr. 5) so they should segregate independently, as the authors indeed say on P7 L178. So I don’t understand why the authors then go on to say that the TT class is only possible “if crossover occurs during interphase I near the uprt or tk locus” (L184), and they don’t cite any reference to support this statement. They then observe that 87-89% of the oocysts are TT (Fig. 2B,D) and they say on line 200 that this frequency is surprisingly high (also on line 229).

In yeast genetics, a cross involving two markers on different chromosomes would result in the ratio of asci classes being 1 PD : 1 NPD : 4 TT, (i.e. 66% of the asci will be tetratype), unless each of the markers is tightly linked to the centromere of its chromosome. See Hiten Madhani’s online notes about yeast tetrad analysis, https://studylib.net/doc/8744127/classical-genetics--tetrad-analysis-and

The manuscript doesn’t say anywhere that the UPRT and TK genes are centromere-linked, so I presume that they are not. So shouldn’t the question be whether the observed 87-89% frequency is statistically higher than the expected 66% ?

Minor comments

Lines 36-37: As a non-specialist, I did not know what an oocyst is until I read the Introduction, so I didn’t initially understand these lines in the Abstract. It would be helpful if you could modify line 36 to say something like “Infection of ALI cultures or Ifngr1 mice with mCherry and GFP parasites resulted in cross-fertilization and formation of “yellow” oocysts (clusters of 4 haploid cells segregating from a meiosis)”.

Lines 120-122 make analogies to classical genetic analysis in yeast, referring to “random oocyst analysis” and “oocyst tetrad dissection”. It would be nice to return to these analogies in the Discussion to discuss them in more detail. The experiment in Figure 1 is random oocyst analysis which in yeast would be equivalent to random ascus analysis (not random spore analysis). The experiment in Figure 2 is oocyst tetrad dissection, OK. The experiments in Figures 3 and 4 are, I think, equivalent to random spore analysis.

Line 183, “parental non-ditype” should be “non-parental ditype”.

In Table 1, please add two columns showing “% of TT oocysts” and “% of TT + other oocysts”.

P11 L275, spell out Cp as “C. parvum”.

Reviewer #3: Mendelian segregation and high recombination rates facilitate genetic analyses in Cryptosporidium parvum

In this paper, isogenic lines of Cryptosporidium parvum were fluorescently tagged with mCherry or GFP on chromosomes 1 or 5 and allowed to undergo hybridization to investigate the frequency of crossing over, and whether chromosomes segregate independently in a Mendelian manner. To do this, the authors took advantage of a method they developed to culture all stages of Cryptosporidium in stem cell derived intestinal epithelial cells grown under air-liquid interface conditions (ALI), which they published in Cell Host and Microbe in 2019. Growth in ALI cultures generates infectious oocysts that are “yellow”, products of cross-fertilization between a red and green parental line. By FACS purifying “yellow” oocysts, and plating these oocysts in conditions that allowed for individual sporozoites from each oocyst to be counted, a technique the authors dubbed as “oocyst tetrad dissection”, the phenotypes of each individual sporozoite from single oocysts were quantified. The authors also produced additional lines that possessed tags that were linked (on the same chromosome), to calculate crossover frequencies, and to determine a recombination rate for each of the two chromosomes queried, which they estimated at between 3-12.1 kb/cM. This work is significant because the researchers applied new assays to study meiosis in Cryptosporidium and they showed, by examining progeny from crosses between transgenic parasites, that Cryptosporidium utilizes both self-fertilization and cross-fertilization, has high rates of recombination, and that chromosomes segregate in a Mendelian manner. In an effort to compare / contrast their results with those of fungi, in which tetrad analysis is pursued as a genetic technique to study recombination events and meiosis, the researchers used terminology such as parental ditype (PD), non-parental ditype (NPD) and tetratype (TT), and specifically showed that yellow oocysts, generated by fertilization between a gamete that had the red fluorescent tag with a gamete that had the green fluorescent tag, largely produced (ranging from 85-89%) an equal frequency (or 1:1:1:1 tetratypes) of progeny that were either dark, red, green, or yellow. This was expected. However, the researchers found this to be unexpected (see Fig 2A), which appears to be a flaw in their logic and needs to be corrected, or better explained.

Major Points:

1. Figures – are generally well received, and the graphics are excellent summaries of the data, but are lacking the visual display of the raw data. In referring back to the CHM paper in 2019, the figures in that manuscript were admixed with raw data plus summarized results. I am not necessarily asking for the same here, but more extensive experimental data could be added to the supplemental section, as seen for example in Suppl. Fig. 1, which provided real insight into some of the nuances of the dataset, and how timing is critical for data collection, to avoid the complications associated with a second round of meiosis, or the time needed post meiotic reduction (14hpi) to sufficiently dilute the inherited cytosolic fluorescent protein of the other parent, to establish which germline encoded fluorescent protein remained stably expressed for a more precise tabulation in the results.

2. Figure 2A – the logic appears to be flawed, and needs to be better explained, and/or corrected. Cryptosporidium is haploid, no genome reduction occurs to produce gametes, rather a developmental queue commits each haploid parasite to differentiate into either a microgamete or a macrogamete, and upon fusion, a 2n zygote forms. There are no perceived mating types, and from the analyses in this paper, there appears to be an equal frequency of self- vs. cross-fertilization occurring. Hence, there is a 50% chance of being either red or green, or 50% chance of being yellow for the two unlinked markers. And for the oocyst tetrad dissection analysis, the predicted outcome would be a 1:1:1:1 ratio in this scenario, hence dark:red:green:yellow progeny (or TT) from each single, yellow oocyst. This is largely what has occurred (Fig 2B and Fig 2D), and is what is predicted, so it is unclear why Figure 2A depicts the opposite, and a paragraph of text is devoted to this as an unexpected result. Minor deviations from this were evident in the results shown. It was the same whether oocyst formatio

Revision 1

Attachments
Attachment
Submitted filename: Resposne to reviewers.docx
Decision Letter - Geraldine Butler, Editor, Joseph Heitman, Editor

Dear David,

We are pleased to inform you that your revised manuscript entitled "Mendelian segregation and high recombination rates facilitate genetic analyses in Cryptosporidium parvum." has been editorially accepted for publication in PLOS Genetics. Congratulations!  I appreciate the care and attention to detail in the revision process.  I would leave it to you to consider whether you might like to thank the reviewers for their astute insights about tetratype recombinants, and how to frame that part of the interpretation of the findings.  They were right on the mark, and I think this is a very nice example where peer review worked to enhance the paper.

Before your submission can be formally accepted and sent to production you will need to complete our formatting changes, which you will receive in a follow up email. Please be aware that it may take several days for you to receive this email; during this time no action is required by you. Please note: the accept date on your published article will reflect the date of this provisional acceptance, but your manuscript will not be scheduled for publication until the required changes have been made.

Once your paper is formally accepted, an uncorrected proof of your manuscript will be published online ahead of the final version, unless you’ve already opted out via the online submission form. If, for any reason, you do not want an earlier version of your manuscript published online or are unsure if you have already indicated as such, please let the journal staff know immediately at plosgenetics@plos.org.

In the meantime, please log into Editorial Manager at https://www.editorialmanager.com/pgenetics/, click the "Update My Information" link at the top of the page, and update your user information to ensure an efficient production and billing process. Note that PLOS requires an ORCID iD for all corresponding authors. Therefore, please ensure that you have an ORCID iD and that it is validated in Editorial Manager. To do this, go to ‘Update my Information’ (in the upper left-hand corner of the main menu), and click on the Fetch/Validate link next to the ORCID field.  This will take you to the ORCID site and allow you to create a new iD or authenticate a pre-existing iD in Editorial Manager.

If you have a press-related query, or would like to know about making your underlying data available (as you will be aware, this is required for publication), please see the end of this email. If your institution or institutions have a press office, please notify them about your upcoming article at this point, to enable them to help maximise its impact. Inform journal staff as soon as possible if you are preparing a press release for your article and need a publication date.

Thank you again for supporting open-access publishing; we are looking forward to publishing your work in PLOS Genetics!  I am especially pleased to see this outstanding study on sexual cycle of Cryptosporidium published in PLOS Genetics---a major advance for the field!

Yours sincerely,

Joe

Joseph Heitman, MD, PhD

Academic Editor

PLOS Genetics

Geraldine Butler

Section Editor

PLOS Genetics

www.plosgenetics.org

Twitter: @PLOSGenetics

----------------------------------------------------

Comments from the reviewers (if applicable):

----------------------------------------------------

Data Deposition

If you have submitted a Research Article or Front Matter that has associated data that are not suitable for deposition in a subject-specific public repository (such as GenBank or ArrayExpress), one way to make that data available is to deposit it in the Dryad Digital Repository. As you may recall, we ask all authors to agree to make data available; this is one way to achieve that. A full list of recommended repositories can be found on our website.

The following link will take you to the Dryad record for your article, so you won't have to re‐enter its bibliographic information, and can upload your files directly: 

http://datadryad.org/submit?journalID=pgenetics&manu=PGENETICS-D-24-00143R1

More information about depositing data in Dryad is available at http://www.datadryad.org/depositing. If you experience any difficulties in submitting your data, please contact help@datadryad.org for support.

Additionally, please be aware that our data availability policy requires that all numerical data underlying display items are included with the submission, and you will need to provide this before we can formally accept your manuscript, if not already present.

----------------------------------------------------

Press Queries

If you or your institution will be preparing press materials for this manuscript, or if you need to know your paper's publication date for media purposes, please inform the journal staff as soon as possible so that your submission can be scheduled accordingly. Your manuscript will remain under a strict press embargo until the publication date and time. This means an early version of your manuscript will not be published ahead of your final version. PLOS Genetics may also choose to issue a press release for your article. If there's anything the journal should know or you'd like more information, please get in touch via plosgenetics@plos.org.

Formally Accepted
Acceptance Letter - Geraldine Butler, Editor, Joseph Heitman, Editor

PGENETICS-D-24-00143R1

Mendelian segregation and high recombination rates facilitate genetic analyses in <i>Cryptosporidium parvum<i>.

Dear Dr Sibley,

We are pleased to inform you that your manuscript entitled "Mendelian segregation and high recombination rates facilitate genetic analyses in <i>Cryptosporidium parvum<i>." has been formally accepted for publication in PLOS Genetics! Your manuscript is now with our production department and you will be notified of the publication date in due course.

The corresponding author will soon be receiving a typeset proof for review, to ensure errors have not been introduced during production. Please review the PDF proof of your manuscript carefully, as this is the last chance to correct any errors. Please note that major changes, or those which affect the scientific understanding of the work, will likely cause delays to the publication date of your manuscript.

Soon after your final files are uploaded, unless you have opted out or your manuscript is a front-matter piece, the early version of your manuscript will be published online. The date of the early version will be your article's publication date. The final article will be published to the same URL, and all versions of the paper will be accessible to readers.

Thank you again for supporting PLOS Genetics and open-access publishing. We are looking forward to publishing your work!

With kind regards,

Lilla Horvath

PLOS Genetics

On behalf of:

The PLOS Genetics Team

Carlyle House, Carlyle Road, Cambridge CB4 3DN | United Kingdom

plosgenetics@plos.org | +44 (0) 1223-442823

plosgenetics.org | Twitter: @PLOSGenetics

Open letter on the publication of peer review reports

PLOS recognizes the benefits of transparency in the peer review process. Therefore, we enable the publication of all of the content of peer review and author responses alongside final, published articles. Reviewers remain anonymous, unless they choose to reveal their names.

We encourage other journals to join us in this initiative. We hope that our action inspires the community, including researchers, research funders, and research institutions, to recognize the benefits of published peer review reports for all parts of the research system.

Learn more at ASAPbio .